Person:
Feng, Xudong

Profile Picture

Email Address

AA Acceptance Date

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Feng

First Name

Xudong

Name

Feng, Xudong

Filters

20181

Settings

Author's Publications: search.filters.isAuthorOfPublication.3c2d1da4-e4d5-4ed3-ac9f-93f912c262ea

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    Publication
    Withaferin A is a Leptin Sensitizer with Strong Anti-Diabetic Properties in Mice
    (2018) Lee, Jaemin; Liu, Junli; Feng, Xudong; Salazar Hernández, Mario Andrés; Mucka, Patrick; Ibi, Dorina; Choi, Jae Won; Ozcan, Umut
    The increasing global prevalence of obesity and its associated disorders point to an urgent need for the development of novel and effective therapeutic strategies that induce healthy weight loss. Obesity is characterized by hyperleptinemia and central leptin resistance. In an attempt to identify compounds that could reverse leptin resistance and thus promote weight loss, we analyzed a library of small molecules with mRNA expression profiles similar to that of celastrol, a naturally-occurring compound we previously identified as a leptin sensitizer. By this process we identified another natural compound, withaferin A, that also acts as a leptin sensitizer. We found that withaferin A treatment of diet-induced obese mice resulted in a 20-25% reduction of body weight, while also decreasing obesity-associated abnormalities including hepatic steatosis. Withaferin A marginally affects the body weight of ob/ob and db/db mice, which are both deficient in leptin signaling. In addition, withaferin A, unlike celastrol, has beneficial effects on glucose metabolism independently from its leptin-sensitizing effect. Our results show that the metabolic abnormalities of diet-induced obesity can be mitigated by sensitizing animals to endogenous leptin, and indicate that withaferin A is a potential leptin sensitizer with additional anti-diabetic actions.